Skip Navigation LinksHome > 3 Control Insect Vectors > Challenges > 8 Chemical Strategy > Molecular Design of Selective Anticholinsterases for Mosquito Control
PRIMARY INVESTIGATOR:
Dr. Jeffery R. Bloomquist, Virginia Tech, Virginia, United States - US
Molecular Design of Selective Anticholinesterases for Mosquito Control
Research ObjectivesProject Progress & Milestones
Collaborators
Project

The malaria parasites’ increased resistance to both medications and insecticides and environmental concerns about the use of traditional insecticides pose major challenges to decreasing the rate and breadth of infection.  In addition, insecticide-treated bed nets periodically must be re-treated to maintain their effectiveness, and most insecticides are too toxic for people to apply safely inside their homes. 

Dr. Bloomquist and his colleagues are using advanced molecular modeling and a novel chemical synthesis method called "click chemistry" in an effort to produce insecticides specifically targeted to the primary malaria vector mosquitoes, Anopheles gambiae. The insecticides would work by inhibiting the essential enzyme acetylcholinesterase (AChE) in mosquitoes. They could be used as a potentially safer and more effective alternative to existing insecticides used in treating bed nets. 
 
Investigators are now working to tether the compounds to appropriate catalytic site structures to achieve their goals. Foremost,  among  these are the design of a highly selective compound for wild type mosquito receptor while maintaining potency for mosquitoes having an insecticide-resistant form of AChE.

Research Objectives:
Express and purify recombinant AChE from the malaria vector An. gambiae, and obtain human AChE for use in screening procedures
Identify unique structural motifs from comparative molecular modeling of AChE enzymes from mosquito and human
Design, synthesize, and screen chemical libraries for inhibition of AChE activity.
Evaluate lead inhibitors for their activity against live mosquitoes in the laboratory, using treated bed net material
Confirm insecticidal efficacy in the field using controlled hut testing in Africa to demonstrate the performance of the compound under environmental conditions typically encountered in the field
Conduct mouse acute toxicity studies to assess mammalian toxicity as a component of a regulatory package pursuant to the commercialization of the relevant insecticide
BACK TO THE TOP
Project Progress & Milestones:
Investigators have identified five compounds that have significant selectivity for inhibition of An. gambiae AChE, compared to the human enzyme. One is 1000-fold selective, and several are ca. 100-fold selective. Without any structural optimization, the compounds are as toxic to mosquitoes in in vivo tests as the currently recommended compounds, with significantly less predicted toxicity in mammals.
These inhibitors are much less potent against a mutant form of AChE that is present in insecticide-resistant An. gambiae. As a result, investigators are exploring the use of bivalent inhibitors, which has shown early promise. By engineering contact with both the catalytic and peripheral sites of the enzyme, investigators have achieved potent inhibition in this mosquito.
Investigators using virtual screening of in silico chemical libraries identified two additional moieties that selectively inhibited activity against the mosquito enzyme by binding to the peripheral site.
BACK TO THE TOP
Collaborators:
Molosoft LLC, California, United States - US
International Centre of Insect Physiology and Ecology, Kenya - KE
BACK TO THE TOP

 Project at a Glance

GOAL:
CHALLENGE:
TECHNOLOGY CATEGORY:
DISEASE MODEL:

 Research Map